Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Treasury Shares (2018 - 2025)

Historic Treasury Shares for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to $5.1 million.

  • Health Catalyst's Treasury Shares changed N/A to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year change of. This contributed to the annual value of $3.5 million for FY2024, which is 1265.66% up from last year.
  • As of Q3 2025, Health Catalyst's Treasury Shares stood at $5.1 million.
  • Health Catalyst's 5-year Treasury Shares high stood at $5.7 million for Q1 2025, and its period low was $145027.0 during Q1 2023.
  • Moreover, its 5-year median value for Treasury Shares was $2.9 million (2021), whereas its average is $2.7 million.
  • The largest annual percentage gain for Health Catalyst's Treasury Shares in the last 5 years was 33878.34% (2023), contrasted with its biggest fall of 9653.42% (2023).
  • Over the past 5 years, Health Catalyst's Treasury Shares (Quarter) stood at $2.3 million in 2021, then tumbled by 68.81% to $709139.0 in 2022, then surged by 338.78% to $3.1 million in 2023, then increased by 12.66% to $3.5 million in 2024, then soared by 45.15% to $5.1 million in 2025.
  • Its Treasury Shares stands at $5.1 million for Q3 2025, versus $5.2 million for Q2 2025 and $5.7 million for Q1 2025.